Skip to main content
. 2023 Apr 10;109(5):1382–1399. doi: 10.1097/JS9.0000000000000302

Table 3.

Subgroup analysis of the PDSIs on invasive treatment choice and decision-making–related outcomes

Test of heterogeneity
Variables Number of trials (references) Pooled estimate (95% CI) I 2 (%) χ2 P χ2, subgroup differences
Invasive treatment choice
 Types of elective surgery
  Breast reconstruction 376,78,83 RR=0.99 (0.83, 1.18) 0.0 1.26 0.53 14.06, P=0.08
  Destination therapy LVAD placement 251,72 RR=0.77 (0.51, 1.15) 80.0 4.99 0.03
  First/repeat cesarean section 459,73,80,87 RR=0.99 (0.87, 1.14) 41.8 5.15 0.16
  Lumbar spine surgery 258,82 RR=0.70 (0.49, 1.01) 19.9 1.25 0.26
  Lumpectomy and/or mastectomy 867,74,77,85,91,101,103,105 RR=1.13 (0.88, 1.46) 59.2 17.14 0.02
  Prophylactic mastectomy/oophorectomy/hysterectomy 5 69,95,96,102 RR=1.12 (1.01, 1.24) 0.0 1.53 0.82
  Prostatectomy/radical prostatectomy or orchidectomy 353,75,97 RR=0.91 (0.65, 1.26) 86.7 15.03 <0.001
  Total knee/hip/joint replacement/arthroplasty 655,65,66,84,89,100 RR=1.01 (0.89, 1.15) 52.7 10.57 0.06
  Othersa 952,61,64,68,90,98,104,106,107 RR=0.87 (0.73, 1.03) 53.5 17.19 0.03
 Mode of delivery
  Clinician-delivered 1151,53,66,67,72,73,90,96,97,101,103 RR=0.88 (0.73, 1.07) 79.2 48.16 <0.001 1.33, P=0.25
  Self-guided 3152,55,58,59,61,64,65,68,69,7478,80,8285,87,89,91,95,98,100,102,104107 RR=1.00 (0.93, 1.07) 52.9 63.74 <0.001
 Consider value
  Yes 2651,59,6469,7378,80,8385,87,89,90,96,97,104,106,107 RR=0.98 (0.90, 1.07) 60.6 63.39 <0.001 0.27, P=0.61
  No 1652,53,55,58,61,72,82,91,95,98,100103,105 RR=0.94 (0.83, 1.07) 71.1 51.95 <0.001
 Use of theoretical framework
  Yes 1251,59,61,64,67,72,77,78,85,87,98,104 RR=0.98 (0.83, 1.17) 61.0 28.23 <0.001 0.03, P=0.87
  No 3052,53,55,58,65,66,68,69,7376,80,8284,8991,9597,100103,105107 RR=0.97 (0.89, 1.05) 66.6 86.73 <0.001
 PROM-based PDSIs
  Yes 366,90,96 RR=1.24 (0.85, 1.81) 0.0 1.64 0.44 1.64, P=0.20
  No 395153,55,58,59,61,6469,7278,80,8285,87,89,91,95,97,98,100107 RR=0.96 (0.90, 1.04) 64.5 112.09 <0.001
Decisional conflict
 Types of elective surgery
  Breast reconstruction 576,78,83,86,99 g=−1.07 (−1.91, −0.23) 92.1 50.63 <0.001 12.80, P=0.03*
  Destination therapy LVAD placement 251,72 g=0.06 (−0.17, 0.29) 0.0 0.69 0.41
  First/repeat cesarean section 273,80 g=−0.13 (−0.38, 0.12) 73.3 3.75 0.05
  Lumpectomy and/or mastectomy 460,74,101,103 g=−0.31 (−0.46, −0.15) 0.0 1.33 0.72
  Total knee/hip/joint replacement/arthroplasty 450,57,84 g=−0.48 (−0.96, 0.01) 86.6 22.31 <0.001
  Othersb 1052,54,56,61,64,71,79,98,104,107 g=−0.16 (−0.29, −0.02) 53.5 19.37 0.02
 Mode of delivery
  Clinician-delivered 651,56,72,73,101,103 g=−0.13 (−0.30, 0.03) 54.5 10.99 0.05 3.21, P=0.07
  Self-guided 2150,52,54,57,60,61,64,71,74,76,7880,83,84,86,98,99,104,107 g=−0.35 (−0.51, −0.18) 81.8 109.78 <0.001
 Consider value
  Yes 1951,54,56,57,60,64,71,73,74,76,78,80,83,84,86,99,104,107 g=−0.31 (−0.48, −0.15) 84.4 115.70 <0.001 0.26, P=0.61
  No 850,52,61,72,79,98,101,103 g=−0.26 (−0.40, −0.12) 28.1 9.73 0.20
 Use of theoretical framework
  Yes 1051,54,61,64,72,78,79,86,98,104 g=−0.29 (−0.54, −0.05) 81.7 49.14 <0.001 0.00, P=1.00
  No 1750,52,56,57,60,71,73,74,76,80,83,84,99,101,103,107 g=−0.29 (−0.45, −0.14) 79.8 79.13 <0.001
 PROM-based PDSIs
  Yes 254,57 g=−0.12 (−0.54, 0.29) 68.4 3.16 0.08 0.65, P=0.42
  No 265052,56,57,60,61,64,7174,76,7880,83,84,86,98,99,101,103,104,107 g=−0.30 (−0.44, −0.17) 80.6 123.68 <0.001
Satisfaction with decision-making
 Types of elective surgery
  Breast reconstruction 363,78,86 g=0.09 (−0.16, 0.35) 31.6 2.92 0.23 0.20, P=1.00
  First/repeat cesarean section 273,80 g=0.13 (−0.25, 0.51) 91.6 11.86 <0.001
  Lumpectomy and/or mastectomy 560,67,77,103,105 g=0.05 (−0.19, 0.30) 54.2 8.74 0.07
  Total knee/hip/joint replacement/arthroplasty 457,66,84 g=0.14 (−0.34, 0.61) 85.8 21.12 <0.001
  Othersc 470,72,98,104 g=0.05 (−0.33, 0.43) 74.1 11.56 0.01
 Mode of delivery
  Clinician-delivered 666,67,70,72,73,103 g=0.20 (−0.05, 0.44) 76.1 20.89 <0.001 1.23, P=0.27
  Self-guided 1257,60,63,77,78,80,84,86,98,104,105 g=0.03 (−0.16, 0.21) 71.6 38.69 <0.001
 Consider value
  Yes 1357,60,66,67,70,73,77,78,80,84,86,104 g=0.11 (−0.06, 0.27) 74.3 46.75 <0.001 0.16, P=0.69
  No 563,72,98,103,105 g=0.04 (−0.25, 0.33) 69.5 13.10 0.01
 Use of theoretical framework
  Yes 867,70,72,77,78,86,98,104 g=0.02 (−0.19, 0.23) 58.2 16.76 0.02 0.57, P=0.45
  No 1057,60,63,66,73,80,84,103,105 g=0.13 (−0.06, 0.32) 79.0 42.89 <0.001
 PROM-based PDSIs
  Yes 257,66 g=0.23 (−0.61, 1.06) 89.6 9.57 <0.001 0.13, P=0.72
  No 1757,60,63,67,70,72,73,77,78,80,84,86,98,103105 g=0.07 (−0.06, 0.21) 68.8 48.03 <0.001
Disease and treatment knowledge
 Types of elective surgery
  First/repeat cesarean section 273,80 g=0.28 (−0.28, 0.83) 95.9 21.11 <0.001 3.90, P=0.42
  Lumpectomy and/or mastectomy 460,74,77,105 g=0.15 (−0.04, 0.34) 17.2 3.62 0.31
  Prophylactic mastectomy/oophorectomy/hysterectomy 279,95 g=0.20 (−0.16, 0.56) 72.2 3.59 0.06
  Total knee/hip/joint replacement/arthroplasty 350,84,89 g=0.39 (0.18, 0.61) 46.8 3.76 0.15
  Othersd 452,78,98,106 g=0.50 (0.06, 0.94) 85.4 20.48 <0.001
 Mode of delivery
  Clinician-delivered 173 g=0.00 (−0.11, 0.11) 12.82, P<0.001**
  Self-guided 1450,52,60,74,7780,84,89,95,98,104,106 g=0.35 (0.19, 0.51) 76.0 54.13 <0.001
 Consider value
  Yes 960,73,74,77,78,80,84,89,106 g=0.39 (0.13, 0.65) 90.3 82.82 <0.001 1.15, P=0.28
  No 650,52,79,95,98,104 g=0.22 (0.07, 0.38) 36.7 7.89 0.16
 Use of theoretical framework
  Yes 47779,98 g=0.20 (−0.01, 0.41) 16.4 3.59 0.31 0.98, P=0.32
  No 1150,52,60,73,74,80,84,89,95,104,106 g=0.35 (0.14, 0.56) 88.5 86.77 <0.001

g, Hedges’s g; I 2, percentage of variation across studies that is due to heterogeneity rather than chance; LVAD, left ventricular assist devices; PDSI, patient decision support intervention; PROM, patient-reported outcome measure; RCT, randomized controlled trial; RR, risk ratio.

aBariatric surgery, cataract surgery, aneurysm repair, lung transplantation, surgical termination of pregnancy, shock wave lithotripsy, and retrograde intrarenal surgery.

bBariatric, cataract, general surgery, lung transplantation, percutaneous coronary intervention, prophylactic mastectomy, prostatectomy, shock wave lithotripsy, and retrograde intrarenal surgery.

cLVAD placement, lung transplantation, and general surgery.

dBariatric surgery, lung transplantation, and surgical termination of pregnancy.

*P<0.05.

**P<0.001.